Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era

By sjmartinez • May 20, 2025

Pohlman N, Patel PN, Essien UR, Tang JJ, Joseph JJ. Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era. J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210/clinem/dgaf295. Epub ahead of print. PMID: 40388382.

Tags: cardiovascular disease, cardiovascular-kidney-metabolic syndrome, General Internal Medicine, Kidney disease, Obesity, Publications, Type 2 diabetes mellitus, Veterans Administration

Dextroposition of the Heart From Tension Hydrothorax in a Patient With Malignant Pleural Effusion

Lu JY, Fritzmann E, Hsia DW, Lanks C. Dextroposition of the Heart From Tension Hydrothorax in a Patient With Malignant Pleural Effusion. Cureus. 2025 Apr[...]

Correction: Clinical Ethnographies of the Politics and Poetics of the US Healthcare Crisis

Buchbinder L, Holmes SM, Newmark R, Wong B, Bourgois P. Correction: Clinical Ethnographies of the Politics and Poetics of the US Healthcare Crisis. Cult Med[...]

Poor clinical outcomes among hospitalized obese patients with COVID-19 are related to inflammation and not respiratory mechanics

Edwards JN, Ganz T, Nemeth E, Martin EJ, Jackson NJ, Kim A. Poor clinical outcomes among hospitalized obese patients with COVID-19 are related to inflammation[...]